Wells Fargo & Company Taysha Gene Therapies, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TSHA
# of Institutions
107Shares Held
136MCall Options Held
65.4KPut Options Held
41.7K-
Rtw Investments, LP New York, NY18.8MShares$43.1 Million0.7% of portfolio
-
Avoro Capital Advisors LLC New York, NY18.7MShares$42.7 Million0.57% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$26.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$24.9 Million0.37% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$20.6 Million2.21% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $111M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...